FundedIQ
Biotechnology

Myome: Funding, Investors & Team (Sep 2026)

Myome distinguishes qualities that cause sickness and act in light of driving science. The information is secure, convenient, and reusable over the course of life.

myome.com LinkedIn Palo Alto, United States 11-50 employees
Biotechnology Life Science
Total raised
$23.0M
Rounds
2
Latest
Undisclosed round
Dec 2025

Myome has raised $23.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Dec 2025.

Myome Company Profile and Key Stats

Total funding raised
$23.0M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Dec 2025
Employees
11-50
reported band
Headquarters
Palo Alto, United States

Latest funding round on record: Dec 2025.

Myome Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Series B
$23.0M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Myome raised $23.0M in a Series B announced in Jun 2022.

3.5 years later, an undisclosed round was announced in Dec 2025 with no disclosed amount.

Myome Founders and Leadership Team

Name
Role
Contact
Kate Im
Founder
Locked

Contact details for the Myome team: 1 of 1 has an email address on file.

Start 14-day free trial →

Myome Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Funded Startups Like Myome in Biotechnology and Palo Alto

Companies Similar to Myome

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Myome Funding FAQs

What does Myome do?

Myome distinguishes qualities that cause sickness and act in light of driving science. The information is secure, convenient, and reusable over the course of life.

How much funding has Myome raised?

Myome has raised $23.0M across 2 rounds on record.

When did Myome last raise funding?

Myome's most recent funding round on record was announced in Dec 2025. The amount was not disclosed.

Who founded Myome?

FundedIQ lists Kate Im (Founder) at Myome.

Where is Myome headquartered?

Myome is based in Palo Alto, California, United States.

How many employees does Myome have?

Myome is in the 11-50 employee band.

About FundedIQ's Myome Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Myome is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.